Advertisement

Topics

Takeda licenses preclinical cardiovascular assets to start-up Cardurion

15:40 EDT 3 Aug 2017 | Elsevier Business Intelligence

Takeda Pharmaceutical Co. Ltd. and start-up Cardurion Pharmaceuticals LLC teamed up to develop next-generation therapies for ...

Original Article: Takeda licenses preclinical cardiovascular assets to start-up Cardurion

NEXT ARTICLE

More From BioPortfolio on "Takeda licenses preclinical cardiovascular assets to start-up Cardurion"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...